Ignite Creation Date:
2024-05-05 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 9:50 AM
Study NCT ID:
NCT00689156
Status:
COMPLETED
Last Update Posted:
2018-04-05
First Post:
2008-05-29
Brief Title:
Epirubicin or Not in Patients With TOP2A Topoisomerase DNA II Alpha 170kD Normal Early Breast Cancer
Sponsor:
Danish Breast Cancer Cooperative Group
Organization:
Danish Breast Cancer Cooperative Group
Organization Data
Organization:
Danish Breast Cancer Cooperative Group
Class:
OTHER
Study ID:
DBCG 07-READ
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Danish Breast Cancer Cooperative Group
Lead Sponsor Class:
OTHER
Responsible Party:
Bent Ejlertsen
Responsible Party Title:
Professor MD PhD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Danish Breast Cancer Cooperative Group
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Fonden Til Fremme af Klinisk- Eksperimentel Cancerforskning | OTHER |
| Sanofi | INDUSTRY |
| Dako | INDUSTRY |